APP and PS-1 mutations induce brain oxidative stress independent of dietary cholesterol: Implications for Alzheimer's disease

Neuroscience Letters

Volumn 368, Issue 2, 2004, Pages 148-150

  Mohmmad Abdul, Hafiz ^a   Wenk, Gary L ^b   Gramling, McGann ^b   Hauss Wegrzyniak, Beatrice ^b   Butterfield, D Allan ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

A (1 42); Alzheimer's disease; Amyloid precursor protein; Cholesterol; Lipid peroxidation; Oxidative stress; Presenilin 1; Protein carbonyl

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; APOLIPOPROTEIN; PROTEIN S;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; CHOLESTEROL INTAKE; COMPARATIVE STUDY; CONTROLLED STUDY; HOMOGENATE; LIPID PEROXIDATION; MOUSE; MUTATION; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ALDEHYDES; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANALYSIS OF VARIANCE; ANIMALS; CHOLESTEROL, DIETARY; IMMUNOBLOTTING; LIPID PEROXIDATION; MEMBRANE PROTEINS; MICE; MICE, TRANSGENIC; OXIDATION-REDUCTION; OXIDATIVE STRESS; PRESENILIN-1;

EID: 4444304720     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2004.06.077     Document Type: Article

References (21)

1. N.A. Avdulov, S.V. Chochina, U. Igbavboa, C.S. Warden, A.V. Vassiliev, and W.G. Wood Lipid binding to amyloid beta-peptide aggregates: preferential binding of cholesterol as compared with phosphatidylcholine and fatty acids J. Neurochem. 69 1997 1746 1752
2. I. Bjorkhem, and S. Meaney Brain cholesterol: long secret life behind a barrier Arterioscler. Thromb. Vasc. Biol. 24 2004 806 815
3. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 72 1976 248 254
4. D.A. Butterfield, and C.M. Lauderback Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress Free Radic. Biol. Med. 32 11 2002
5. D.A. Butterfield, and E.R. Stadtman Protein oxidation processes in aging brain Adv. Cell Aging Gerontol. 2 1997 161 191
6. K. Duff, C. Eckman, C. Zehr, X. Yu, C.M. Prada, J. Perez-Tur, M. Hutton, L. Buee, Y. Harigaya, D. Yager, D. Morgan, M.N. Gordon, L. Holcomb, L. Refolo, B. Zenk, J. Hardy, and S. Younkin Increased amyloid-β42 in brains of mice expressing mutant presenilin 1 Nature 383 1996 710 713
7. K. Fassbender, M. Simons, C. Bergmann, M. Stroick, D. Lutjohann, P. Keller, H. Runz, S. Kuhl, T. Bertsch, K. von Bergmann, M. Hennerici, K. Beyreuther, and T. Hartmann Simvastatin strongly reduces levels of Alzheimer's disease beta-amyloid peptides Aβ42 and Aβ40 in vitro and in vivo Proc. Natl. Acad. Sci. U.S.A. 98 2001 5856 5861
8. K. Hsiao, P. Chapman, S. Nilsen, C. Eckman, Y. Harigaya, S. Younkin, F. Yang, and G. Cole Correlative memory deficits Aβ elevation, and amyloid plaques in transgenic mice Science 274 1996 99 102
9. H. Jick, G. Zornberg, L.S. Jick, S.S. Seshadri, and D.A. Drachman Statins and the risk of dementia Lancet 356 2000 1627 1631
10. M. Kivipelto, E.L. Helkala, T. Hanninen, M. Laakso, P. Hallikainen, M. Alhainen, K. Soininen, H. Tuomilehto, and J.A. Nissinen Midlife vascular risk factors and late-life mild cognitive impairment. A population based study Neurology 56 2001 1683 1689
11. C.M. Lauderback, J.M. Hackett, F.F. Huang, J.N. Keller, L.I. Szweda, W.R. Markesbery, and D.A. Butterfield The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: the role of Abeta1-42 J. Neurochem. 78 2001 413 416
12. U. Laufs, K. Gertz, U. Dirnagl, M. Bohm, G. Nickenig, and M. Endres Rosuvastatin, a new HMG-CoA reductase inhibitor, upregulates endothelial nitric oxide synthase and protects from ischemic stroke in mice Brain Res. 942 2002 23 30
13. T. Mori, D. Paris, T. Town, A.M. Rojiani, D.L. Sparks, A. Delledonne, F. Crawford, L.I. Abdullah, J.A. Humphrey, D.W. Dickson, and M.J. Mullan Cholesterol accumulates in senile plaques of Alzheimer disease patients and in transgenic APP (SW) mice J. Neuropathol. Exp. Neurol. 60 2001 778 785
14. I.L. Notkola, R. Sulkava, J. Pekkanen, T. Erkinjuntti, C. Ehnholm, P. Kivinen, J. Tuomilehto, and A. Nissinen Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease Neuroepidemiology 17 1 1998 14 20
15. L. Puglielli, R.E. Tanzi, and D.M. Kovacs Alzheimer's disease: the cholesterol connection Nat. Neurosci. 6 4 2003 345 351
16. G. Ransmayr Cholesterol and statins in Alzheimer disease Wien. Med. Wochenschr. 153 2003 258 259
17. L.M. Refolo, M.A. Pappolla, B. Malester, J. LaFrancois, S.D. Schmidt, T. Thomas-Bryant, R. Wang, G.S. Tint, K. Sambamurti, and K. Duff Hypercholesterolemia accelerates the Azheimer's amyloid pathology in a transgenic mouse model Neurobiol. Dis. 7 2000 321 331
18. D.L. Sparks, S.W. Scheff, J.C. Hunsaker III, H. Liu, T. Landers, and D.R. Gross Induction of Alzheimer-like beta-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol Exp. Neurol. 126 1994 88 94
19. B. Wolozin, W. Kellman, P. Ruosseau, G.G. Celesia, and G. Siegel Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3- methyglutaryl coenzyme A reductase inhibitors Arch. Neurol. 57 2000 1439 1443
20. K. Yanagisawa Cholesterol and pathological processes in Alzheimer's Disease J. Neurosci. Res. 70 2002 361 366
21. S.G. Younkin Evidence that Aβ42 is the real culprit in Alzheimer's disease Ann. Neurol. 37 1995 287 288